• No results found

Meningococcal vaccine

Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers

Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers

... compulsory meningococcal vaccine among mainly domestic Hajj pilgrims, and, for the first time, it provides insight into some of the barriers to ...the vaccine as vaccinated; however, since some ...

13

Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older

Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older

... MenACWY vaccine administration is recommended for college freshman because of increased invasive meningococcal disease attributable to serogroups in the conjugate meningococcal vaccine in ...

9

Henoch-Schonlein Purpura Following a Meningococcal Vaccine

Henoch-Schonlein Purpura Following a Meningococcal Vaccine

... incidence, vaccine protection is short, and the vaccine is not very effective in children ⬍ 2 years old, who are most likely to have sporadic ...The meningococcal vaccine is recommended for ...

6

Henoch-Schönlein Purpura and Polysaccharide Meningococcal Vaccine

Henoch-Schönlein Purpura and Polysaccharide Meningococcal Vaccine

... 2 meningococcal vaccines available in United States. The vaccine used from 1981 until the present time is the meningococcal polysaccharide vaccine, MPV4 (Meno- mune [Aventis Pasteur, ...

7

Adoption of Serogroup B Meningococcal Vaccine Recommendations

Adoption of Serogroup B Meningococcal Vaccine Recommendations

... MenB vaccine for adolescents 16 to 18 years of age, whereas being only somewhat or not at all aware of the MenB vaccine and practicing in a health maintenance organization (HMO) compared with a private ...

12

Protocol for a controlled human infection with genetically modified Neisseria lactamica expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine

Protocol for a controlled human infection with genetically modified Neisseria lactamica expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine

... A greater understanding of the mucosal immune mech- anisms of protection from colonisation is essential for the development and evaluation of new vaccines, specifically ones targeting colonisation and transmis- sion. The ...

10

Impact of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer blind, phase 3 randomised clinical trial

Impact of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer blind, phase 3 randomised clinical trial

... Table 3: Odds Ratios GEE model for carriage prevalence of N meningitidis in 4CMenB and control groups at any timepoint from three months after second vaccination visits 4 to 6 – MITT pop[r] ...

31

Understanding the Category B Recommendation for Serogroup B Meningococcal Vaccine

Understanding the Category B Recommendation for Serogroup B Meningococcal Vaccine

... MenB vaccine assigned Category B rather than Category A for healthy adolescents? Simply speaking, there was not enough evidence to recommend that all 16- to 18-year-olds receive the vaccine, but there was ...

5

Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine

Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine

... the meningococcal vaccine-naïve group, participants must have had no his- tory of meningococcal ...any vaccine ⬍ 14 days before or ⬍ 14 days after study entry; a history of ...

6

Immunogenicity of MenACWY CRM in Korean Military Recruits: Influence of Tetanus Diphtheria Toxoid Vaccination on the Vaccine Response to MenACWY CRM

Immunogenicity of MenACWY CRM in Korean Military Recruits: Influence of Tetanus Diphtheria Toxoid Vaccination on the Vaccine Response to MenACWY CRM

... meningococcal vaccine. Subjects were exclud- ed if they had a history of meningococcal disease, a disease re- quiring treatment with immunosuppressive drugs, a history of hypersensitivity to vaccines ...

6

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine

... Meningitis Vaccine Project (MVP), a public-private partnership between WHO and the Program for Appropriate Technology in Health (PATH), has developed MenAfriVac, an effective monovalent serogroup A conjugate ...

9

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

Critical appraisal of a quadrivalent CRM<sub>197</sub> conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo<sup>&reg;</sup>) in the context of treatment and prevention of invasive disease

... Similar results were observed in adults enrolled into a Phase III study in Latin America. The majority of healthy adults #55 years of age had robust immune responses to Men- ACWY-CRM and MenACWY-D. In a cohort of 326 ...

11

Carriage rates of Neisseria meningitides serogroups: determination among freshmen conscripts before vaccination

Carriage rates of Neisseria meningitides serogroups: determination among freshmen conscripts before vaccination

... of meningococcal carriage in the United States is 5–10% under non-epidemic condi- ...invasive meningococcal disease (14). In addition, the incidence of meningococcal disease outbreaks in military ...

7

Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine

Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine

... of meningococcal disease in the matched ...of meningococcal disease, a proxy such as a parent was ...of meningococcal vaccine, including date of vaccination, vaccine type, and lot ...

10

Harberger_unc_0153D_17600.pdf

Harberger_unc_0153D_17600.pdf

... HPV vaccine is recommended for 11-12 year olds for the prevention of HPV-related ...(Tdap) vaccine and Meningococcal vaccine, HPV vaccination rates remain low and trail Tdap and ...

96

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

... polysaccharide vaccine hyporesponsive- ness with repeated doses led investigators to study whether MenACWY-TT immunogenicity is affected in subjects who had previously received PS ...MenACWY-TT vaccine ...

15

Genetic Variants in Toll-Like Receptor 2 (TLR2), TLR4, TLR9, and FCγ Receptor II Are Associated with Antibody Response to Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth

Genetic Variants in Toll-Like Receptor 2 (TLR2), TLR4, TLR9, and FCγ Receptor II Are Associated with Antibody Response to Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth

... invasive meningococcal disease (1). The most common invasive meningococcal serogroups are A, B, C, W135, and ...conjugate vaccine (MCV4) is targeted against the other four invasive ...The ...

7

Molecular and Serological Diversity of Neisseria meningitidis Carrier Strains Isolated from Italian Students Aged 14 to 22 Years

Molecular and Serological Diversity of Neisseria meningitidis Carrier Strains Isolated from Italian Students Aged 14 to 22 Years

... In conclusion, two main groups of carrier isolates were distin- guished in our study. On one side, we found isolates genetically unable to express a functional capsule because they were missing the capsule operon (60). ...

10

UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis

UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis

... of differing views according to the number of children a parent had. As with all interview studies, there may have been some ‘social desirability’ in participants’ accounts and responses could have been influenced by ...

10

Epidemiological Status of Bacterial Meningitis Disease Following the Introduction of the Meningococcal A Conjugate Vaccine in the African Meningitis Belt

Epidemiological Status of Bacterial Meningitis Disease Following the Introduction of the Meningococcal A Conjugate Vaccine in the African Meningitis Belt

... Meningitis remains a burden for the 26 countries of the African meningitis belt, stretching from Senegal in the west to Ethiopia in the east [1, 2]. The bacterial is a serious infection of the meninges, thin fibrous ...

11

Show all 5599 documents...

Related subjects